ClinicalTrials.Veeva

Menu

Efficacy and Safety Study of Catheter Ablation for Atrial Fibrillation

W

Wuhan University

Status and phase

Unknown
Phase 4

Conditions

Atrial Fibrillation

Treatments

Procedure: catheter ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT01113294
AFCT001

Details and patient eligibility

About

To compare the efficacy of different procedures, identify the optimal procedure, ablation sites, ablation endpoints and post-operative anticoagulation strategy, establish the optimal treatment strategy for atrial fibrillation.

Enrollment

2,040 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Atrial fibrillation recorded by ECG or Holter;
  2. Age: 18 ~ 75 years;
  3. Patients who are willing to enroll in the trial

Exclusion criteria

  1. Patients accompanied hyperthyroidism;
  2. Patients with sever liver or renal dysfunction;
  3. Patients with sever cardiac dysfunction;
  4. Patients had previous radiofrequency catheter ablation in the LA or Maze surgical procedure;
  5. Patients with emboli in atrium;
  6. Pregnant woman

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,040 participants in 1 patient group

ablation
Experimental group
Treatment:
Procedure: catheter ablation

Trial contacts and locations

1

Loading...

Central trial contact

Cong-xin Huang, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems